Alex De Caluwé

6PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER<sup>+</sup>HER2<sup>-</sup> breast cancer: a randomized phase 2 trial.

|Dec 06, 2023
First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial.

Alex De Caluwe, Emanuela Romano, Philip Poortmans

|Feb 13, 2023
Immunotherapy in breast cancer: an overview of current strategies and perspectives.

Véronique Debien, Alex De Caluwé, Xiaoxiao Wang

|Feb 11, 2023
Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges.

Xiaoxiao Wang, Laetitia Collet, Mattia Rediti

|Nov 11, 2022
Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer.

Elisa Agostinetto, Flavia Jacobs, Véronique Debien

|Aug 07, 2021
Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial.

Alex De Caluwé, Laurence Buisseret, Philip Poortmans

Pageof 1

Frequent Collaborators

4 joint publications

Laurence Buisseret

2 joint publications

Elisa Agostinetto

2 joint publications

Christos Sotiriou

2 joint publications

Emanuela Romano